2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients

Clinical trial NCT06432166 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06432166
Sponsor: MTI Biotech Inc
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease Mild Cognitive Impairment

Start date: 2025-09-01
Primary completion: 2028-06-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.